MyAverix Finance
US · Healthcare
Nanobiotix (NBTX)
Biotechnology
Nanobiotix (NBTX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NBTX
P/E ratio
25.00
Nanobiotix (NBTX) — FAQ
What is NBTX's P/E ratio?
The price-to-earnings (P/E) ratio for Nanobiotix (NBTX) is 25.00 (data as of 2026-05-23).
Does Nanobiotix pay a dividend?
Dividend yield is not available in the current snapshot for Nanobiotix (NBTX). Check the MyAverix Finance app for the latest dividend data.
What sector is Nanobiotix in?
Nanobiotix (NBTX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is NBTX listed on?
NBTX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.